Result Summary for 114010
| Protocol ID: | 114010 |
| Clinical Study ID: | SIR114010 |
| Official Title: | A Phase IIa, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects with Type 2 Diabetes Mellitus |
| Phase: | phase 2 |
| Study Indications or Diseases: |
|
| Generic Name: | SRT2104 |
| Trade/Product Name: | SRT2104 |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
